Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

NCT00473343 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
102
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galderma R&D